Packaging of the Russian vaccine «EpiVacCorona» for the prevention of COVID-19 at the pharmaceutical company «Geropharm» in the Moscow regionMOSCOW , Jan 25 The remains of EpiVacCorona are sufficient to meet the current needs of medical institutions, Assistant Minister of Health Alexei Kuznetsov told RIA Novosti. «Drugs for vaccination against COVID-19 are purchased based on need, taking into account indications for use and contraindications. The current balances of EpiVacCorona drugs fully satisfy the existing need for them,» he said. MediaEarlier, the Vedomosti newspaper wrote that not a single batch of vaccines from the Novosibirsk center «Vector» has been distributed to the regions since the beginning of the year. most subjects and is actively used for immunization. At the same time, the next order from the Ministry of Health is expected in February. They specified that in 2021, about 13 million doses were produced and put into civilian circulation. Vaccination remains the most reliable way to protect against coronavirus. Sputnik V, its one-component version Light and KoviVak are also available, and several more drugs are under development. patients in hospitals are unvaccinated.
